## APH: Amphenol Corporation - XLK: Technology

### Executive Summary

VALUE thesis: PEG 1.20 indicates fundamental undervaluation. Quality metrics strong (ROE 35%, ROA 14%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($130.72)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-13 | Barclays | $143 | $120 | +19% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-13 | Barclays | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 6 ($17.45M) |
| Sells | 7 ($16.94M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 10.2% (-10.9%)
- Blackrock Inc.: 8.2% (+6.7%)
- FMR, LLC: 8.1% (-8.1%)
- State Street Corpora: 4.6% (+1.2%)
- Price (T.Rowe) Assoc: 3.6% (+5.8%)

### Key Risks

1. Heavy insider selling: $17M sold (7 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.20 suggests fair value with growth premium. Quality metrics strong (ROE 35%, ROA 14%, margin 18%). Balance sheet: strong liquidity (2.1x), $1.2B free cash flow. Analyst sentiment positive (1 raises, avg +19%). Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $169.8B |
| Beta | 1.19 |
| 52W Range | $56.45 - $144.37 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.20 |
| Forward P/E | 34.7 |
| Current P/E | 41.9 |
| YoY Growth | 21.0% |
| EPS Direction | RISING |

### Technicals

MRS_20 weakening modestly (-0.6% over 5 days). Below STRENGTH zone by 5.4pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 54.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.39% (CS: 43) | Neutral |
| RSI_14 | 53.6 | Neutral |
| MACD Histogram | -0.21 | Bearish |
| vs SMA20 | 1.010x | Above |
| vs SMA50 | 1.037x | Above |
| vs SMA200 | 1.364x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $138.68
- **Stop Loss:** $130.72 (5.7% risk)
- **Target:** $154.60 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 150
- **Position Value:** $20,802.00
- **Portfolio %:** 20.80%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with signs of improving risk appetite. Multiple major banks lowering prime rates suggest a dovish tilt in financial conditions ahead of the FOMC, while volatility remains subdued and breadth is moderate. Key drivers are easing lending rates, stable macro data, and improving sentiment, but selectivity is needed due to sector divergences.*

### Earnings

**Next:** 2026-01-28 (Est: $0.94)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.80 | $0.93 | +16.5% |
| 2025Q2 | $0.67 | $0.81 | +21.7% |
| 2025Q1 | $0.52 | $0.63 | +21.0% |
| 2024Q4 | $0.50 | $0.55 | +9.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*